Robert DeBernardo, MD
Associate Professor
Cleveland Clinic
9500 Euclid Avenue
Cleveland,
OH
USA
44195
Papers:
97 - Featured Poster
A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: a GOG study
230 - Poster Session A
An analysis of short-term morbidity associated with intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer
394 - Poster Session B
Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women
395 - Poster Session B
The impact of obesity on 30-day morbidity and mortality after surgery for endometrial cancer